DBV Technologies (DBVT) Net Cash Flow Growth (3y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 89.97% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -13.44% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 33.37% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -29.82% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 32.17% |
| 10 | DBV Technologies | 8.00 Bn | 7.77 Bn | -3.90 Mn | 57.38% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 57.38% |
| Dec 31, 2025 | 92.10% |
| Sep 30, 2025 | -16.25% |
| Jun 30, 2025 | -23.40% |
| Mar 31, 2025 | -132.42% |
| Dec 31, 2024 | 17.04% |
| Sep 30, 2024 | 2.14% |
| Jun 30, 2024 | -5.28% |
| Mar 31, 2024 | -0.86% |
| Dec 31, 2023 | 25.67% |
| Sep 30, 2023 | 22.22% |
| Mar 31, 2023 | -30.22% |
| Dec 31, 2022 | -29.91% |
| Sep 30, 2022 | 25.94% |
| Jun 30, 2022 | 60.47% |
| Dec 31, 2021 | 60.96% |
| Sep 30, 2021 | -41.02% |
| Jun 30, 2021 | 27.62% |
| Dec 31, 2020 | 38.02% |
| Dec 31, 2019 | 54.89% |
| Dec 31, 2018 | -215.01% |
| Dec 31, 2017 | -127.91% |